The primary market is set to take a breather in the holiday-shortened week, with no new initial public offerings (IPOs) scheduled to open for subscription. However, action will continue on the listing front, with four mainboard IPOs - Central Mine Planning & Design, Amir Chand Jagdish Kumar (Exports), Powerica, and Sai Parenteral - slated to debut on the Bombay Stock Exchange and National Stock Exchange.

These four mainboard IPOs collectively raised over ₹3,791 crore in the previous week.

Indian stock markets will remain closed on March 31 for Mahavir Jayanti and again on April 3 for Good Friday.

IPO listings this week:

CMPDI IPO

The ₹1,842-crore IPO of Central Mine Planning & Design Institute, the consultancy arm of Coal India, received a muted response, with overall subscription at 1.05 times. The issue, entirely an offer for sale (OFS) of 10.71 crore shares, will see proceeds going to selling shareholders.

The IPO closed on March 24, with allotment finalised on March 25. The stock is scheduled to list on both exchanges on March 30. CMPDI is among India’s largest coal and mineral consultancy firms, commanding an estimated 61% market share in FY25.

Amir Chand Jagdish Kumar (Exports) IPO

The ₹440-crore IPO of rice exporter Amir Chand Jagdish Kumar (Exports) was subscribed 3.23 times. The issue, entirely a fresh issue of 2.08 crore shares, had a price band of ₹201-₹212 per share.

The IPO closed on March 24, with allotment expected on March 30. The company is likely to list on April 2. Incorporated in 2003, the firm operates across the basmati rice value chain, including procurement, processing, and distribution.

Powerica IPO

The IPO of Powerica Limited saw healthy demand, with subscription at 3.67 times. The company raised around ₹1,100 crore through the issue.

Powerica provides integrated power solutions, including diesel generator sets ranging from 7.5 kVA to 10,000 kVA. It also has a growing renewable energy portfolio, operating 12 wind power projects in Gujarat with a total capacity of 330.85 MW, and an additional 52.70 MW project under development.

The IPO closed on March 27, with allotment due on March 30 and listing scheduled for April 2.

Sai Parenteral IPO

The ₹408.79-crore IPO of Sai Parenteral Limited was subscribed 1.08 times. The issue comprises a fresh issue of ₹285 crore and an offer for sale of ₹123.79 crore, with a price band of ₹372-₹392 per share.

The IPO closed on March 27, with allotment expected on March 30. The company is set to list on April 2. Incorporated in 2001, Sai Parenteral is a pharmaceutical formulations player with capabilities in research, development, and manufacturing.